X4 Pharmaceuticals
Clinical trials sponsored by X4 Pharmaceuticals, explained in plain language.
A biopharmaceutical company focused on developing therapies for rare immune system diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug aims to boost immune cells in rare blood disorder Results expected Sep 2027 (estimated) 🚀 Make-or-break